We’re excited to have been part of hashtag#TAT13 in Rio!
It was a fantastic opportunity to connect with the community, exchange ideas, and see the field continuing to move forward at an impressive pace.
One particularly exciting highlight was a very recent development pointing to the clinical potential of astatine-211, with early clear indications of efficacy in humans emerging from ongoing clinical trials at Osaka University with [211At]PSMA-5. Astatine appears to work. We’re proud to be part of it.
Thank you to the organisers for hosting such a well-run and engaging event.
#KeenOnAstatine #astatine211 #TargetedAlphaTherapy #Radiopharmaceuticals #Innovation
